An Open-label, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HS-10504 on the Pharmacokinetics of Midazolam in Patients With Non-small Cell Lung Cancer

NCT07685041 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

NSCLC

Interventions

DRUG: HS-10504； midazolam

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.